Chemed Corporation $CHE Shares Purchased by Hsbc Holdings PLC

Hsbc Holdings PLC grew its stake in shares of Chemed Corporation (NYSE:CHE) by 41.7% during the second quarter, HoldingsChannel reports. The firm owned 12,346 shares of the company’s stock after buying an additional 3,632 shares during the period. Hsbc Holdings PLC’s holdings in Chemed were worth $5,729,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Quantbot Technologies LP purchased a new position in shares of Chemed in the second quarter valued at $1,726,000. The Manufacturers Life Insurance Company purchased a new position in Chemed in the second quarter valued at about $4,413,000. TD Asset Management Inc grew its stake in Chemed by 7.5% during the 4th quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock valued at $138,860,000 after purchasing an additional 22,715 shares in the last quarter. BNP Paribas Financial Markets increased its holdings in Chemed by 14.5% during the 4th quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company’s stock worth $14,985,000 after purchasing an additional 4,430 shares during the last quarter. Finally, Epoch Investment Partners Inc. raised its position in shares of Chemed by 4.9% in the 4th quarter. Epoch Investment Partners Inc. now owns 322,408 shares of the company’s stock valued at $137,945,000 after purchasing an additional 15,133 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $539.51, for a total transaction of $1,079,020.00. Following the sale, the chief executive officer directly owned 70,418 shares in the company, valued at $37,991,215.18. The trade was a 2.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Spencer S. Lee sold 1,000 shares of the company’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $541.04, for a total transaction of $541,040.00. Following the completion of the sale, the executive vice president directly owned 13,912 shares of the company’s stock, valued at $7,526,948.48. The trade was a 6.71% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 5,190 shares of company stock worth $2,803,460. 3.33% of the stock is owned by company insiders.

Chemed Stock Performance

Shares of CHE opened at $518.12 on Thursday. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $557.00. The company has a market cap of $6.77 billion, a price-to-earnings ratio of 26.02, a price-to-earnings-growth ratio of 1.97 and a beta of 0.51. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. The firm has a fifty day moving average of $519.73 and a 200-day moving average of $452.69.

Chemed (NYSE:CHE) last released its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, topping analysts’ consensus estimates of $5.60 by $0.46. The business had revenue of $673.25 million for the quarter, compared to analysts’ expectations of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The company’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter last year, the company earned $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, equities analysts anticipate that Chemed Corporation will post 23.18 earnings per share for the current year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th were given a dividend of $0.70 per share. This is a boost from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date was Monday, August 17th. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. Chemed’s payout ratio is presently 14.06%.

Analyst Ratings Changes

CHE has been the subject of a number of research analyst reports. Oppenheimer lifted their price target on shares of Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a research note on Friday, July 31st. Wall Street Zen upgraded Chemed from a “hold” rating to a “strong-buy” rating in a research report on Saturday, August 1st. Bank of America reissued a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Finally, Royal Bank Of Canada boosted their price objective on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research report on Thursday, July 30th. One investment analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, Chemed presently has a consensus rating of “Hold” and an average target price of $530.75.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.